Neurological disorders are the major cause of disability, leading to a decrease in quality of
life by impairing cognitive, sensorimotor, and motor functioning. Several factors have been …

Anti-epileptic drugs (AEDs) are an important group of drugs of several generations, ranging
from the oldest phenobarbital (1912) to the most recent cenobamate (2019). Cannabidiol …

Importance Increasing evidence indicates that carbamazepine (CBZ) treatment in people
with epilepsy (PWE) has adverse effects on bone health. Objective We conducted a meta …

Introduction Vitamin D is an essential micronutrient that participates in the body's
fundamental physiological processes. The pharmacist should involve the patient in his …

Objective To assess vitamin D status of children on long-term anticonvulsants, including the
less studied widely used levetiracetam, and the potential risk factors for deficiency. Method …

Objective: Data on changes in bone mineral density (BMD) from valproate (VPA) therapy are
ambiguous and conflicting. Thus, the aim of this study was to systematically review the …

Major depressive disorder (MDD) presents multiple clinical phenotypes and has complex
underlying pathological mechanisms. Existing theories cannot completely explain the …

Methods: A case-control study has been carried out to compare vitamin D3 levels in 50
epileptic children who were treated with valproic acid with 50 healthy children selected from …

Objective To compare the serum 25-OH-VitD levels, the major marker of vitamin D (VitD)
status, between healthy children and children with epilepsy before initiation of and during …

To evaluate if valproic acid (VPA) therapy is associated with vitamin D deficiency among
infants and toddlers with epilepsy, a cross-sectional clinical study was conducted in 25 …